HomeCVKD • NASDAQ
add
Cadrenal Therapeutics Inc
Previous close
$4.97
Day range
$4.86 - $5.13
Year range
$4.21 - $17.50
Market cap
12.66M USD
Avg Volume
45.45K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.07M | -28.36% |
Net income | -3.04M | 27.42% |
Net profit margin | — | — |
Earnings per share | -1.41 | 83.85% |
EBITDA | -3.06M | 28.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.01M | -59.99% |
Total assets | 4.33M | -57.26% |
Total liabilities | 1.59M | -40.83% |
Total equity | 2.74M | — |
Shares outstanding | 2.51M | — |
Price to book | 4.25 | — |
Return on assets | -182.14% | — |
Return on capital | -279.99% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.04M | 27.42% |
Cash from operations | -2.57M | -43.52% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 2.72M | -63.53% |
Net change in cash | 147.71K | -97.39% |
Free cash flow | -1.45M | -409.46% |
About
Founded
2022
Website
Employees
5
